TKI and Interferon Alpha Evaluation Initiated by the German Chronic Myeloid Leukemia Study Group - the TIGER Study

NCT01657604 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

717

Enrollment

OTHER

Sponsor class

Conditions

Chronic Myeloid Leukemia

Interventions

DRUG: Peginterferon α2b
DRUG: Nilotinib

Sponsor

University of Jena